Liposomal cytarabine in cerebrospinal fluid
Unexpected glucose-6-phosphate dehydrogenase deficiency
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions
Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis – a personal view
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity : implications for a phase I clinical study
The protein kinase C agonist PEP005 increases NF-κB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate
Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation
A risk score for the management of pregnant women with increased risk of venous thromboembolism : a multicentre prospective study
VEGF/KDR loop is a target of AG1296 in acute myeloid leukaemia showing FLT3-internal tandem duplications
Is ‘Virchow's triad’ useful?
Is ‘Virchow's triad’ useful? – response to Malone and Agutter
A new VKORC1 mutation leading to an isolated resistance to fluindione
Hb Southern Italy : coexistence of two missence mutations (the Hb Sun Prairie α2 130 Ala > Pro and Hb Caserta α2 26 Ala > Thr) in a single HBA2 gene